← Back to Clinical Trials
Recruiting NCT06084078

NCT06084078 Rural Illinois Lung Cancer Screening Initiative

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06084078
Status Recruiting
Phase
Sponsor Southern Illinois University
Condition Lung Cancer
Study Type OBSERVATIONAL
Enrollment 10,000 participants
Start Date 2024-09-01
Primary Completion 2029-08-31

Eligibility & Interventions

Sex All sexes
Min Age 50 Years
Max Age 80 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 10,000 participants in total. It began in 2024-09-01 with a primary completion date of 2029-08-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The role of this observational study is to access the feasibility of providing lung cancer screening using a designated nurse navigator through lung cancer screening clinic. Eligible participants will be identified using medical records, eligibility will be confirmed through phone call, screening visits will be scheduled as in-person visit or telehealth visit. Computed tomography screening will be performed at an approved center closer to the individuals place of living and results will be discussed during follow-up in-person visit or telehealth visit.

Eligibility Criteria

Inclusion Criteria: * All individuals 50-80 years of age * 20 pack-year smoking history * Currently smoke or have quit within the past 15 years: Exclusion Criteria: * Individuals 49 years and below or 81 years and above * Has not smoked in 15 or more years * Individuals who develop a health problem that makes them unwilling or unable to have surgery if lung cancer is detected.

Contact & Investigator

Central Contact

Sowmy Thuppal, MD PhD

✉ sthuppal83@siumed.edu

📞 217-545-2320

Principal Investigator

Sowmy Thuppal, MD PhD

PRINCIPAL INVESTIGATOR

Southrn Illinois University School of Medicine

Frequently Asked Questions

Who can join the NCT06084078 clinical trial?

This trial is open to participants of all sexes, aged 50 Years or older, up to 80 Years, studying Lung Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06084078 currently recruiting?

Yes, NCT06084078 is actively recruiting participants. Contact the research team at sthuppal83@siumed.edu for enrollment information.

Where is the NCT06084078 trial being conducted?

This trial is being conducted at Springfield, United States.

Who is sponsoring the NCT06084078 clinical trial?

NCT06084078 is sponsored by Southern Illinois University. The principal investigator is Sowmy Thuppal, MD PhD at Southrn Illinois University School of Medicine. The trial plans to enroll 10,000 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology